Association even stronger for additive-originated nitrites and sodium nitrites
WEDNESDAY, Jan. 18, 2023 (HealthDay News) — Total nitrites and additive-originated nitrites are linked to higher diabetes risk, according to a study published online Jan. 17 in PLOS Medicine.
Bernard Srour, Ph.D., M.P.H., from Sorbonne Paris Nord University, and colleagues examined the association between nitrites/nitrates and type 2 diabetes (T2D), distinguishing foods and water-originated nitrites/nitrates from those from food additives. The analysis included self-reported exposures from 104,168 adults followed for a median 7.3 years.
The researchers found that total nitrites and foods and water-originated nitrites were both positively associated with a higher T2D risk (tertile 3 versus 1: hazard ratios, 1.27 and 1.26, respectively). Compared with those who were not exposed to additives-originated nitrites, participants with higher exposure (i.e., above the sex-specific median), and specifically those having higher exposure to sodium nitrite (e250), had a higher T2D risk (higher consumers versus nonconsumers: hazard ratios, 1.53 and 1.54, respectively). There was no association seen between total, foods and water-originated, or additives-originated nitrates and T2D risk.
“These results provide a new piece of evidence in the context of current discussions regarding the need for a reduction of nitrite additives’ use in processed meats by the food industry, and could support the need for better regulation of soil contamination by fertilizers,” the authors write.
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors
2009 to 2023 Saw Surge in Probiotic Supplement Use
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD
Report Highlights Substance Use in Young Adults in U.S. in 2025
Considerable Gaps Identified in LDL Cholesterol Control
Link Between Liver Fibrosis in MASLD, ASCVD Varies by Glycemic Status
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk